Literature DB >> 11422870

Melatonin therapy for REM sleep behavior disorder.

N Takeuchi1, N Uchimura, Y Hashizume, M Mukai, Y Etoh, K Yamamoto, T Kotorii, H Ohshima, M Ohshima, H Maeda.   

Abstract

Rapid eye movement sleep behavior disorder (RBD) is a parasomnia with clinical symptoms that include punching, kicking, yelling and leaping out of bed in sleep. Polysomnographic (PSG) finding showed REM sleep without muscle atonia. Clonazepam is generally used for treating RBD symptoms but melatonin was reported to be effective so we reconfirmed the effect of melatonin on RBD patients in the present study. We used melatonin (3-9 mg/day) which could ameliorate problem sleep behaviors remarkably, as well as %tonic activity in PSG variables. In the present study, melatonin was reconfirmed to be effective in RBD symptoms, especially for patients with low melatonin secretion, while its mechanism was not clearly known in the present study.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11422870     DOI: 10.1046/j.1440-1819.2001.00854.x

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN: 1323-1316            Impact factor:   5.188


  43 in total

Review 1.  Diagnostic tools for REM sleep behavior disorder.

Authors:  Ariel B Neikrug; Sonia Ancoli-Israel
Journal:  Sleep Med Rev       Date:  2011-12-14       Impact factor: 11.609

Review 2.  Melatonin antioxidative defense: therapeutical implications for aging and neurodegenerative processes.

Authors:  Seithikurippu R Pandi-Perumal; Ahmed S BaHammam; Gregory M Brown; D Warren Spence; Vijay K Bharti; Charanjit Kaur; Rüdiger Hardeland; Daniel P Cardinali
Journal:  Neurotox Res       Date:  2012-06-28       Impact factor: 3.911

Review 3.  REM sleep behaviour disorder in older individuals: epidemiology, pathophysiology and management.

Authors:  Lynn Marie Trotti
Journal:  Drugs Aging       Date:  2010-06-01       Impact factor: 3.923

4.  Update on parasomnias: a review for psychiatric practice.

Authors:  Dimitri Markov; Fredric Jaffe; Karl Doghramji
Journal:  Psychiatry (Edgmont)       Date:  2006-07

5.  Therapeutic potential of melatonin and its analogs in Parkinson's disease: focus on sleep and neuroprotection.

Authors:  Venkatramanujam Srinivasan; Daniel P Cardinali; Uddanapalli S Srinivasan; Charanjit Kaur; Gregory M Brown; D Warren Spence; Rüdiger Hardeland; Seithikurippu R Pandi-Perumal
Journal:  Ther Adv Neurol Disord       Date:  2011-09       Impact factor: 6.570

6.  Neurodegenerative Disease and REM Behavior Disorder.

Authors:  Raman Malhotra; Alon Y Avidan
Journal:  Curr Treat Options Neurol       Date:  2012-10       Impact factor: 3.598

Review 7.  Treatment of REM Sleep Behavior Disorder.

Authors:  Youngsin Jung; Erik K St Louis
Journal:  Curr Treat Options Neurol       Date:  2016-11       Impact factor: 3.598

Review 8.  Treatment of Sleep Dysfunction in Parkinson's Disease.

Authors:  Amy W Amara; Lana M Chahine; Aleksandar Videnovic
Journal:  Curr Treat Options Neurol       Date:  2017-07       Impact factor: 3.598

9.  Treatment of sleep disorders in elderly patients.

Authors:  John J Harrington; Alon Y Avidan
Journal:  Curr Treat Options Neurol       Date:  2005-09       Impact factor: 3.598

10.  Drug treatment of REM sleep behavior disorder: the use of drug therapies other than clonazepam.

Authors:  Kirstie N Anderson; John M Shneerson
Journal:  J Clin Sleep Med       Date:  2009-06-15       Impact factor: 4.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.